SandboxAQ · 2 months ago
Director of Commercial Partnerships, Biopharma
United States
Full-time
Remote
Director/Executive
$192K/yr - $269K/yr
10+ years expSandboxAQ is a high-growth company delivering AI solutions that address significant global challenges. As the Director of Commercial Partnerships, Biopharma, you will lead negotiations and develop partnerships with leading pharmaceutical and biotech companies to redefine drug discovery and development.
Artificial Intelligence (AI)Cyber SecurityInformation TechnologyQuantum ComputingSaaS
Responsibilities
Leverage your industry network to generate high-value, top of funnel opportunities
Architect and lead negotiations for partnerships, structure aligned incentives, and licensing deals where there is no playbook. This includes: M&A, joint ventures, licensing, and equity investments spanning the full lifecycle from strategy formulation and evaluation to negotiation and closing
Act as a core member of deal teams, working closely with engineering, science, legal, and finance stakeholders to manage transactions from initial partner interactions through final execution
Redefine how pharma and biotech engage with AI simulation, creating new partnership models that unlock transformative therapeutic breakthroughs
Structure and analyze complex financial terms for all corporate development opportunities, leveraging your deep expertise in business planning, financial modeling, and P&L analysis
Be the trusted commercial leader in the room, complementing deep technical expertise with business vision, financial acumen, and relational mastery
Provide direct business and operational consultancy to senior and executive management, advising on strategic decisions that shape our current and future product portfolio
Anticipate and resolve issues quietly and effectively, maintaining momentum and strengthening trust across stakeholders and customers
Develop decision frameworks and prepare comprehensive deal presentations for executive management, effectively communicating the strategic rationale and financial implications of potential transactions
Cultivate and expand C-suite relationships across pharma and biotech, ensuring SandboxAQ becomes the partner of choice for strategic innovation
Drive account growth by ensuring continuous value creation, long-term trust and expanding offerings
Represent SandboxAQ at industry forums and thought-leadership platforms, amplifying our impact and reputation
Qualification
Required
10-15 years of experience in biopharma technology business development, strategic transactions, and/or commercial leadership, with a significant portion of that time as a negotiation lead
Secured Biopharma deals with a minimum of $20M+ upfront and biobucks milestones exceeding $100M
Strong financial modeling, business planning, and P&L analysis skills and are able to structure, model, and communicate detailed financial models and complex term sheets
Deep understanding of legal frameworks governing biotech and pharma transactions
Demonstrated proficiency in Salesforce and its customizations for customer management and revenue tracking
Willingness to travel up to 30%, as needed
Preferred
Expert at navigating complex deals where novel scientific software and technical capabilities are core components
While an advanced degree such as an MBA or PhD in a biology, chemistry, or related field is advantageous, we prioritize candidates with a proven track record of building and executing transformative commercial partnerships in the biopharma and tech-bio industry
Architected first of its kind high profile deals that have been featured e.g. in FiercePharma or FierceBiotech
Benefits
Competitive salaries
Stock options depending on employment type
Generous learning opportunities
Medical/dental/vision
Family planning/fertility
PTO (summer and winter breaks)
Financial wellness resources
401(k) plans
And more
Company
SandboxAQ
SandboxAQ develops AI and quantum technology solutions that enhance biopharma, cybersecurity, and materials science.
51-200 employees
Funding
Current Stage
Late StageTotal Funding
$975MKey Investors
Eric Schmidt Angel InvestmentsMichael J. Fox Foundation
2025-04-04Series E· $150M
2024-12-18Series E· $300M
2024-10-29Grant· $25M
Leadership Team
Jack Hidary
Chief Executive Officer
Joerg Rathenberg
Head Of Marketing
Recent News
2026-01-10
Company data provided by crunchbase